Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
pharmaceutical intermediate
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
This compound is a pharmaceutical intermediate used in the synthesis of ponatinib, a targeted cancer therapy. It is a benzamide derivative containing an ethynyl group, a trifluoromethyl-substituted aromatic ring, and a piperazine moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
3-ethynyl-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
BYPNAYSWCCERGN-UHFFFAOYSA-N
CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#C